セルバンキングアウトソーシングの世界市場

【英語タイトル】Cell Banking Outsourcing Market Analysis By Bank Type, By Cell Type, By Phase (Bank Preparation, Storage, Characterization & Testing, Safety Testing, Viral, Microbial Banks, Gene Expression, Karyology, Gene Sequencing Testing) And Segment Forecasts To 2022

Grand View Researchが出版した調査資料(GVR808SP22PL)・商品コード:GVR808SP22PL
・発行会社(調査会社):Grand View Research
・発行日:2016年3月
・ページ数:179
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2営業日)
・調査対象地域:グローバル
・産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,450 ⇒換算¥502,850見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,450 ⇒換算¥728,850見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Global cell banking outsourcing market size was valued at USD 2.93 billion in 2014 and is expected to grow at an estimated CAGR of 16.4% from 2015 to 2022. Key growth drivers include the rising advancement of cryopreservation and cell banks preparation methodologies, increasing adoption of stem cell therapies, and growing demand for monoclonal antibodies and effective biopharmaceuticals.

The industry involves the collection, storage, characterization, and testing of cells, cell lines, and tissues. It is yet to gain its complete market potential. Advantages associated with cell banking include the availability of cell lines that play a significant role in clinical R&D, production of biopharmaceuticals with maximum effectiveness and minimal adverse events.

Furthermore, development of precision and regenerative medicine, and treatment of chronic infections diseases using stem cell therapy are expected to propel the growth of this market. Stem cell banking market accounts for a large share of the market owing to widespread usage across the globe.

Master cell banking accounted for the largest share of revenue in 2014, as their preparation is a prerequisite for production and usage of working cell banks. They are preserved for a significantly longer duration, which also attracts the application of high-grade cryopreservation methodologies and equipment thereby further expanding the revenue base for this segment.

Furthermore, master cell banks find applicability in various research and development perspectives for stem cell therapy and gene therapy. Rising incidences of autoimmune diseases and cancer that can be treated by use of the aforementioned therapies in combination with regenerative medicine is a key factor expected to fuel the growth of this segment over the forecast period.

North America dominated the market in 2014, with revenue estimated over USD 1.5 billion owing to the presence of biopharmaceutical manufacturers, rising production of vaccines, therapeutic proteins, and antibiotics.

Regulatory authorities such as FDA, WHO, EMEA, and International Conference on Harmonization of technical requirements for registration of pharmaceuticals for human use (ICH) facilitate cell culture and research practices worldwide.

The presence of favorable government initiatives pertaining to the R&D for development of stable cell lines, the introduction of new technology for storage and characterization of cell lines are amongst the critical factors expected to boost market growth over the forecast period.

Key cell banking outsourcing market players include BioReliance, BioOutsource (Sartorious), BSL Bioservice, Cleancells, Charles River Laboratories, Covance, GlobalStem Inc., Goodwin Biotechnology Inc., Lonza, PX’Therapeutics SA, SGS Life Sciences, Texcell, Toxikon Corporation, Wuxi Apptec, Reliance Life Sciences, LifeCell International Pvt. Ltd., Cryobanks International India, Cryo-Cell International Inc., Tran-Scell Biologics, Pvt. Ltd., and CordLife.

【レポートの目次】

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Cell Banking Outsourcing Industry Outlook
3.1 Market segmentation
3.2 Market size and growth prospects, 2012 – 2022
3.3 Cell banking outsourcing market dynamics
3.3.1 Market driver analysis
3.3.1.1 Technological advancement involving cell banking
3.3.1.2 Increasing vaccine production
3.3.1.3 Patent expiration of blockbuster biologics
3.3.1.4 Rising demand for monoclonal antibodies
3.3.1.5 Growing R&D investments in biotechnology sector
3.3.1.6 Increasing prevalence of cancer
3.3.2 Market restraint analysis
3.3.2.1 Ethical concern related to stem cell research
3.4 Key Opportunities Prioritized
3.5 Industry analysis – Porter’s
3.6 Cell banking PESTEL Analysis
3.7 Overall R&D expenses
3.8 Cell therapy
3.9 Gene therapy
3.10 Vaccines
3.11 r-Proteins
3.12 Cell banking needs for cell line
3.12.1 Cell line preparation and banking
3.12.2 Cell line storage
3.12.3 Quality estimation of cell lines
Chapter 4 Cell Banking Outsourcing Outlook by Bank Type
4.1 Global cell banking revenue share, by bank type, 2014 & 2022
4.2 Master cell banking
4.2.1 Master cell banking market, 2012 – 2022 (USD Million)
4.3 Working cell banking
4.3.1 Working cell banking market, 2012 – 2022 (USD Million)
4.4 Viral cell banking
4.4.1 Viral cell banking market, 2012 – 2022 (USD Million)
Chapter 5 Cell Banking Outsourcing Outlook by Cell Type
5.1 Global cell banking revenue share, by cell type, 2014 & 2022
5.2 Stem cell banking
5.2.1 Stem cell banking market, 2012 – 2022 (USD Million)
5.2.2 Cord cell banking
5.2.2.1 Cord cell banking market, 2012 – 2022 (USD Million)
5.2.3 Embryonic cell banking
5.2.3.1 Embryonic cell banking market, 2012 – 2022 (USD Million)
5.2.4 Adult stem cell banking
5.2.4.1 Adult stem cell banking market, 2012 – 2022 (USD Million)
5.2.5 Dental stem cell banking
5.2.5.1 Dental stem cell banking market, 2012 – 2022 (USD Million)
5.2.6 IPS stem cell banking
5.2.6.1 IPS stem cell banking market, 2012 – 2022 (USD Million)
5.3 Non-stem cell banking
5.3.1 Non-stem cell banking market, 2012 – 2022 (USD Million)
Chapter 6 Cell Banking Outsourcing Phase Outlook
6.1 Global cell banking revenue share, by phase, 2014 & 2022
6.2 Cell bank storage
6.2.1 Cell bank storage market, 2012 – 2022 (USD Million)
6.2.2 Master cell bank storage
6.2.2.1 Master cell bank storage market, 2012 – 2022 (USD Million)
6.2.3 Working cell bank storage
6.2.3.1 Working cell bank storage market, 2012 – 2022 (USD Million)
6.2.4 Cell storage stability testing
6.2.4.1 Cell storage stability testing market, 2012 – 2022 (USD Million)
6.3 Bank characterization and testing
6.3.1 Bank characterization and testing market, 2012 – 2022 (USD Million)
6.3.2 Safety testing
6.3.2.1 Safety testing market, 2012 – 2022 (USD Million)
6.3.2.1.1 Viral cell bank safety testing
6.3.2.1.2 Viral cell bank safety testing market, 2012 – 2022 (USD Million)
6.3.2.1.3 Microbial cell bank safety testing
6.3.2.1.4 Microbial cell bank safety testing market, 2012 – 2022 (USD Million)
6.3.3 Gene expression testing
6.3.3.1 Gene expression testing market, 2012 – 2022 (USD Million)
6.3.4 Karyology testing
6.3.4.1 Karyology testing market, 2012 – 2022 (USD Million)
6.3.5 Gene sequencing testing
6.3.5.1 Gene sequencing testing market, 2012 – 2022 (USD Million)
6.4 Cell bank preparation
6.4.1 Cell bank preparation market, 2012 – 2022 (USD Million)
6.4.1.1 Master cell bank preparation
6.4.1.1.1 Master cell bank preparation market, 2012 – 2022 (USD Million)
6.4.1.2 Working cell bank preparation
6.4.1.2.1 Working cell bank preparation market, 2012 – 2022 (USD Million)
Chapter 7 Cell Banking Outsourcing Regional Outlook
7.1 Cell banking revenue share, by region, 2014 & 2022
7.2 North America
7.2.1 North America cell banking market, 2012 – 2022 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. cell banking market, 2012 – 2022 (USD Million)
7.2.3 Canada
7.2.3.1 Canada cell banking market, 2012 – 2022 (USD Million)
7.3 Europe
7.3.1 Europe cell banking market, 2012 – 2022 (USD Million)
7.3.2 Germany
7.3.2.1 Germany cell banking market, 2012 – 2022 (USD Million)
7.3.3 France
7.3.3.1 France cell banking market, 2012 – 2022 (USD Million)
7.3.4 UK
7.3.4.1 UK cell banking market, 2012 – 2022 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific cell banking market, 2012 – 2022 (USD Million)
7.4.2 Japan
7.4.2.1 Japan cell banking market, 2012 – 2022 (USD Million)
7.4.3 China
7.4.3.1 China cell banking market, 2012 – 2022 (USD Million)
7.4.4 India
7.4.4.1 India cell banking market, 2012 – 2022 (USD Million)
7.4.5 Korea
7.4.5.1 Korea cell banking market, 2012 – 2022 (USD Million)
7.4.6 Singapore
7.4.6.1 Singapore cell banking market, 2012 – 2022 (USD Million)
7.5 Latin America
7.5.1 Latin America cell banking market, 2012 – 2022 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil cell banking market, 2012 – 2022 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico cell banking market, 2012 – 2022 (USD Million)
7.6 MEA
7.6.1 MEA cell banking market, 2012 – 2022 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa cell banking market, 2012 – 2022 (USD Million)
Chapter 8 Competitive Landscape
8.1 BioReliance
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Product Benchmarking
8.2 BioOutsource/Sartorius
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Product Benchmarking
8.3 BSL Bioservice
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Product Benchmarking
8.3.4 Strategic Initiatives
8.4 Cleancells
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Product Benchmarking
8.4.4 Strategic Initiatives
8.5 Charles River Laboratories
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Product Benchmarking
8.5.4 Strategic Initiatives
8.6 Covance
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Product Benchmarking
8.7 GlobalStem Inc.
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Product Benchmarking
8.8 Goodwin Biotechnology Inc.
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Product Benchmarking
8.9 Lonza
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.9.4 Strategic Initiatives
8.10 PX’Therapeutics SA
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Product Benchmarking
8.10.4 Strategic Initiatives
8.11 SGS Life Sciences
8.11.1 Company Overview
8.11.2 Financial Performance
8.11.3 Product Benchmarking
8.11.4 Strategic Initiatives
8.12 Texcell
8.12.1 Company Overview
8.12.2 Financial Performance
8.12.3 Product Benchmarking
8.13 Toxikon Corporation
8.13.1 Company Overview
8.13.2 Financial Performance
8.13.3 Product Benchmarking
8.14 Wuxi Apptec
8.14.1 Company Overview
8.14.2 Financial Performance
8.14.3 Product Benchmarking
8.15 Reliance Life Sciences
8.15.1 Company Overview
8.15.2 Financial Performance
8.15.3 Product Benchmarking
8.16 LifeCell International Pvt. Ltd.
8.16.1 Company Overview
8.16.2 Financial Performance
8.16.3 Product Benchmarking
8.16.4 Strategic Initiatives
8.17 Cryobanks International India
8.17.1 Company Overview
8.17.2 Financial Performance
8.17.3 Product Benchmarking
8.18 Cryo-Cell International Inc.
8.18.1 Company Overview
8.18.2 Financial Performance
8.18.3 Product Benchmarking
8.18.4 Strategic Initiatives
8.19 Tran-Scell Biologics Pvt. Ltd.
8.19.1 Company Overview
8.19.2 Financial Performance
8.19.3 Product Benchmarking
8.20 CordLife
8.20.1 Company Overview
8.20.2 Financial Performance
8.20.3 Product Benchmarking
8.20.4 Strategic Initiatives

List of Tables

TABLE 1 Cell Banking Outsourcing – Industry Snapshot & Key Buying Criteria, 2012 – 2022
TABLE 2 Global cell banking market, by type, 2012 – 2022 (USD Million)
TABLE 3 Global cell banking market, by cell type, 2012 – 2022 (USD Million)
TABLE 4 Global cell banking market, by phase, 2012 – 2022 (USD Million)
TABLE 5 Cell banking outsourcing market, by region, 2012 – 2022 (USD Million)
TABLE 6 Cell banking outsourcing key market driver analysis
TABLE 7 Global cancer incidences, 2012
TABLE 8 Cell banking outsourcing key market restraint analysis
TABLE 9 Comparison of autologous and allogenic cell therapies
TABLE 10 Comparison of HEK 293, A549, insect cells & Sf9 gene therapies
TABLE 11 Comparison of MRC, VERO, Hep-2, WI38 (Part 1)
TABLE 12 Comparison of MRC, VERO, Hep-2, WI38 (Part 2)
TABLE 13 Comparison of CHO and NS0 r-Proteins
TABLE 14 North America cell banking market, by type, 2012 – 2022 (USD Million)
TABLE 15 North America cell banking market, by cell type, 2012 – 2022 (USD Million)
TABLE 16 North America stem cell banking market, by product, 2012 – 2022 (USD Million)
TABLE 17 North America cell banking market, by phase, 2012 – 2022 (USD Million)
TABLE 18 North America cell bank storage market, by product, 2012 – 2022 (USD Million)
TABLE 19 North America cell bank characterization & testing market, by product, 2012 – 2022 (USD Million)
TABLE 20 North America cell bank safety testing market, by product, 2012 – 2022 (USD Million)
TABLE 21 North America cell bank preparation market, by product, 2012 – 2022 (USD Million)
TABLE 22 U.S. cell banking market, by type, 2012 – 2022 (USD Million)
TABLE 23 U.S. cell banking market, by cell type, 2012 – 2022 (USD Million)
TABLE 24 U.S. stem cell banking market, by product, 2012 – 2022 (USD Million)
TABLE 25 U.S. cell banking market, by phase, 2012 – 2022 (USD Million)
TABLE 26 U.S. cell bank storage market, by product, 2012 – 2022 (USD Million)
TABLE 27 U.S. cell bank characterization & testing market, by product, 2012 – 2022 (USD Million)
TABLE 28 U.S. cell bank safety testing market, by product, 2012 – 2022 (USD Million)
TABLE 29 U.S. cell bank preparation market, by product, 2012 – 2022 (USD Million)
TABLE 30 Canada cell banking market, by type, 2012 – 2022 (USD Million)
TABLE 31 Canada cell banking market, by cell type, 2012 – 2022 (USD Million)
TABLE 32 Canada stem cell banking market, by product, 2012 – 2022 (USD Million)
TABLE 33 Canada cell banking market, by phase, 2012 – 2022 (USD Million)
TABLE 34 Canada cell bank storage market, by product, 2012 – 2022 (USD Million)
TABLE 35 Canada cell bank characterization & testing market, by product, 2012 – 2022 (USD Million)
TABLE 36 Canada cell bank safety testing market, by product, 2012 – 2022 (USD Million)
TABLE 37 Canada cell bank preparation market, by product, 2012 – 2022 (USD Million)
TABLE 38 Europe cell banking market, by type, 2012 – 2022 (USD Million)
TABLE 39 Europe cell banking market, by cell type, 2012 – 2022 (USD Million)
TABLE 40 Europe stem cell banking market, by product, 2012 – 2022 (USD Million)
TABLE 41 Europe cell banking market, by phase, 2012 – 2022 (USD Million)
TABLE 42 Europe cell bank storage market, by product, 2012 – 2022 (USD Million)
TABLE 43 Europe cell bank characterization & testing market, by product, 2012 – 2022 (USD Million)
TABLE 44 Europe cell bank safety testing market, by product, 2012 – 2022 (USD Million)
TABLE 45 Europe cell bank preparation market, by product, 2012 – 2022 (USD Million)
TABLE 46 Germany cell banking market, by type, 2012 – 2022 (USD Million)
TABLE 47 Germany cell banking market, by cell type, 2012 – 2022 (USD Million)
TABLE 48 Germany stem cell banking market, by product, 2012 – 2022 (USD Million)
TABLE 49 Germany cell banking market, by phase, 2012 – 2022 (USD Million)
TABLE 50 Germany cell bank storage market, by product, 2012 – 2022 (USD Million)
TABLE 51 Germany cell bank characterization & testing market, by product, 2012 – 2022 (USD Million)
TABLE 52 Germany cell bank safety testing market, by product, 2012 – 2022 (USD Million)
TABLE 53 Germany cell bank preparation market, by product, 2012 – 2022 (USD Million)
TABLE 54 France cell banking market, by type, 2012 – 2022 (USD Million)
TABLE 55 France cell banking market, by cell type, 2012 – 2022 (USD Million)
TABLE 56 France stem cell banking market, by product, 2012 – 2022 (USD Million)
TABLE 57 France cell banking market, by phase, 2012 – 2022 (USD Million)
TABLE 58 France cell bank storage market, by product, 2012 – 2022 (USD Million)
TABLE 59 France cell bank characterization & testing market, by product, 2012 – 2022 (USD Million)
TABLE 60 France cell bank safety testing market, by product, 2012 – 2022 (USD Million)
TABLE 61 France cell bank preparation market, by product, 2012 – 2022 (USD Million)
TABLE 62 UK cell banking market, by type, 2012 – 2022 (USD Million)
TABLE 63 UK cell banking market, by cell type, 2012 – 2022 (USD Million)
TABLE 64 UK stem cell banking market, by product, 2012 – 2022 (USD Million)
TABLE 65 UK cell banking market, by phase, 2012 – 2022 (USD Million)
TABLE 66 UK cell bank storage market, by product, 2012 – 2022 (USD Million)
TABLE 67 UK cell bank characterization & testing market, by product, 2012 – 2022 (USD Million)
TABLE 68 UK cell bank safety testing market, by product, 2012 – 2022 (USD Million)
TABLE 69 UK cell bank preparation market, by product, 2012 – 2022 (USD Million)
TABLE 70 Asia Pacific cell banking market, by type, 2012 – 2022 (USD Million)
TABLE 71 Asia Pacific cell banking market, by cell type, 2012 – 2022 (USD Million)
TABLE 72 Asia Pacific stem cell banking market, by product, 2012 – 2022 (USD Million)
TABLE 73 Asia Pacific cell banking market, by phase, 2012 – 2022 (USD Million)
TABLE 74 Asia Pacific cell bank storage market, by product, 2012 – 2022 (USD Million)
TABLE 75 Asia Pacific cell bank characterization & testing market, by product, 2012 – 2022 (USD Million)
TABLE 76 Asia Pacific cell bank safety testing market, by product, 2012 – 2022 (USD Million)
TABLE 77 Asia Pacific cell bank preparation market, by product, 2012 – 2022 (USD Million)
TABLE 78 Japan cell banking market, by type, 2012 – 2022 (USD Million)
TABLE 79 Japan cell banking market, by cell type, 2012 – 2022 (USD Million)
TABLE 80 Japan stem cell banking market, by product, 2012 – 2022 (USD Million)
TABLE 81 Japan cell banking market, by phase, 2012 – 2022 (USD Million)
TABLE 82 Japan cell bank storage market, by product, 2012 – 2022 (USD Million)
TABLE 83 Japan cell bank characterization & testing market, by product, 2012 – 2022 (USD Million)
TABLE 84 Japan cell bank safety testing market, by product, 2012 – 2022 (USD Million)
TABLE 85 Japan cell bank preparation market, by product, 2012 – 2022 (USD Million)
TABLE 86 China cell banking market, by type, 2012 – 2022 (USD Million)
TABLE 87 China cell banking market, by cell type, 2012 – 2022 (USD Million)
TABLE 88 China stem cell banking market, by product, 2012 – 2022 (USD Million)
TABLE 89 China cell banking market, by phase, 2012 – 2022 (USD Million)
TABLE 90 China cell bank storage market, by product, 2012 – 2022 (USD Million)
TABLE 91 China cell bank characterization & testing market, by product, 2012 – 2022 (USD Million)
TABLE 92 China cell bank safety testing market, by product, 2012 – 2022 (USD Million)
TABLE 93 China cell bank preparation market, by product, 2012 – 2022 (USD Million)
TABLE 94 India cell banking market, by type, 2012 – 2022 (USD Million)
TABLE 95 India cell banking market, by cell type, 2012 – 2022 (USD Million)
TABLE 96 India stem cell banking market, by product, 2012 – 2022 (USD Million)
TABLE 97 India cell banking market, by phase, 2012 – 2022 (USD Million)
TABLE 98 India cell bank storage market, by product, 2012 – 2022 (USD Million)
TABLE 99 India cell bank characterization & testing market, by product, 2012 – 2022 (USD Million)
TABLE 100 India cell bank safety testing market, by product, 2012 – 2022 (USD Million)
TABLE 101 India cell bank preparation market, by product, 2012 – 2022 (USD Million)
TABLE 102 Korea cell banking market, by type, 2012 – 2022 (USD Million)
TABLE 103 Korea cell banking market, by cell type, 2012 – 2022 (USD Million)
TABLE 104 Korea stem cell banking market, by product, 2012 – 2022 (USD Million)
TABLE 105 Korea cell banking market, by phase, 2012 – 2022 (USD Million)
TABLE 106 Korea cell bank storage market, by product, 2012 – 2022 (USD Million)
TABLE 107 Korea cell bank characterization & testing market, by product, 2012 – 2022 (USD Million)
TABLE 108 Korea cell bank safety testing market, by product, 2012 – 2022 (USD Million)
TABLE 109 Korea cell bank preparation market, by product, 2012 – 2022 (USD Million)
TABLE 110 Singapore cell banking market, by type, 2012 – 2022 (USD Million)
TABLE 111 Singapore cell banking market, by cell type, 2012 – 2022 (USD Million)
TABLE 112 Singapore stem cell banking market, by product, 2012 – 2022 (USD Million)
TABLE 113 Singapore cell banking market, by phase, 2012 – 2022 (USD Million)
TABLE 114 Singapore cell bank storage market, by product, 2012 – 2022 (USD Million)
TABLE 115 Singapore cell bank characterization & testing market, by product, 2012 – 2022 (USD Million)
TABLE 116 Singapore cell bank safety testing market, by product, 2012 – 2022 (USD Million)
TABLE 117 Singapore cell bank preparation market, by product, 2012 – 2022 (USD Million)
TABLE 118 Latin America cell banking market, by type, 2012 – 2022 (USD Million)
TABLE 119 Latin America cell banking market, by cell type, 2012 – 2022 (USD Million)
TABLE 120 Latin America stem cell banking market, by product, 2012 – 2022 (USD Million)
TABLE 121 Latin America cell banking market, by phase, 2012 – 2022 (USD Million)
TABLE 122 Latin America cell bank storage market, by product, 2012 – 2022 (USD Million)
TABLE 123 Latin America cell bank characterization & testing market, by product, 2012 – 2022 (USD Million)
TABLE 124 Latin America cell bank safety testing market, by product, 2012 – 2022 (USD Million)
TABLE 125 Latin America cell bank preparation market, by product, 2012 – 2022 (USD Million)
TABLE 126 Brazil cell banking market, by type, 2012 – 2022 (USD Million)
TABLE 127 Brazil cell banking market, by cell type, 2012 – 2022 (USD Million)
TABLE 128 Brazil stem cell banking market, by product, 2012 – 2022 (USD Million)
TABLE 129 Brazil cell banking market, by phase, 2012 – 2022 (USD Million)
TABLE 130 Brazil cell bank storage market, by product, 2012 – 2022 (USD Million)
TABLE 131 Brazil cell bank characterization & testing market, by product, 2012 – 2022 (USD Million)
TABLE 132 Brazil cell bank safety testing market, by product, 2012 – 2022 (USD Million)
TABLE 133 Brazil cell bank preparation market, by product, 2012 – 2022 (USD Million)
TABLE 134 Mexico cell banking market, by type, 2012 – 2022 (USD Million)
TABLE 135 Mexico cell banking market, by cell type, 2012 – 2022 (USD Million)
TABLE 136 Mexico stem cell banking market, by product, 2012 – 2022 (USD Million)
TABLE 137 Mexico cell banking market, by phase, 2012 – 2022 (USD Million)
TABLE 138 Mexico cell bank storage market, by product, 2012 – 2022 (USD Million)
TABLE 139 Mexico cell bank characterization & testing market, by product, 2012 – 2022 (USD Million)
TABLE 140 Mexico cell bank safety testing market, by product, 2012 – 2022 (USD Million)
TABLE 141 Mexico cell bank preparation market, by product, 2012 – 2022 (USD Million)
TABLE 142 MEA cell banking market, by type, 2012 – 2022 (USD Million)
TABLE 143 MEA cell banking market, by cell type, 2012 – 2022 (USD Million)
TABLE 144 MEA stem cell banking market, by product, 2012 – 2022 (USD Million)
TABLE 145 MEA cell banking market, by phase, 2012 – 2022 (USD Million)
TABLE 146 MEA cell bank storage market, by product, 2012 – 2022 (USD Million)
TABLE 147 MEA cell bank characterization & testing market, by product, 2012 – 2022 (USD Million)
TABLE 148 MEA cell bank safety testing market, by product, 2012 – 2022 (USD Million)
TABLE 149 MEA cell bank preparation market, by product, 2012 – 2022 (USD Million)
TABLE 150 South Africa cell banking market, by type, 2012 – 2022 (USD Million)
TABLE 151 South Africa cell banking market, by cell type, 2012 – 2022 (USD Million)
TABLE 152 South Africa stem cell banking market, by product, 2012 – 2022 (USD Million)
TABLE 153 South Africa cell banking market, by phase, 2012 – 2022 (USD Million)
TABLE 154 South Africa cell bank storage market, by product, 2012 – 2022 (USD Million)
TABLE 155 South Africa cell bank characterization & testing market, by product, 2012 – 2022 (USD Million)
TABLE 156 South Africa cell bank safety testing market, by product, 2012 – 2022 (USD Million)
TABLE 157 South Africa cell bank preparation market, by product, 2012 – 2022 (USD Million)

List of Figures

FIG. 1 Cell banking outsourcing market segmentation
FIG. 2 Global cell banking market, 2012 – 2022 (USD Million)
FIG. 3 Cell banking market dynamics
FIG. 4 Key opportunities prioritized
FIG. 5 Cell banking market Porter’s analysis
FIG. 6 Cell banking market PESTEL analysis
FIG. 7 Qualitative share of overall R&D expenses in Cell Banking Technologies
FIG. 8 Cell banking revenue share, by bank type, 2014 & 2022
FIG. 9 Master cell banking market, 2012 – 2022 (USD Million)
FIG. 10 Working cell banking markets, 2012 – 2022 (USD Million)
FIG. 11 Viral cell banking market , 2012 – 2022 (USD Million)
FIG. 12 Cell banking revenue share, by cell type, 2014 & 2022
FIG. 13 Stem cell banking market , 2012 – 2022 (USD Million)
FIG. 14 Cord cell banking market , 2012 – 2022 (USD Million)
FIG. 15 Embryonic cell banking market , 2012 – 2022 (USD Million)
FIG. 16 Adult stem cell banking market , 2012 – 2022 (USD Million)
FIG. 17 Dental stem cell banking market , 2012 – 2022 (USD Million)
FIG. 18 IPS stem cell banking market , 2012 – 2022 (USD Million)
FIG. 19 Non-stem cell banking market , 2012 – 2022 (USD Million)
FIG. 20 Cell banking revenue share, by phase, 2014 & 2022
FIG. 21 Cell bank storage market, 2012 – 2022 (USD Million)
FIG. 22 Master cell bank storage market, 2012 – 2022 (USD Million)
FIG. 23 Working cell bank storage market, 2012 – 2022 (USD Million)
FIG. 24 Cell storage stability testing market , 2012 – 2022 (USD Million)
FIG. 25 Bank characterization and testing market , 2012 – 2022 (USD Million)
FIG. 26 Safety testing market, 2012 – 2022 (USD Million)
FIG. 27 Viral cell bank safety testing market , 2012 – 2022 (USD Million)
FIG. 28 Microbial cell bank safety testing market , 2012 – 2022 (USD Million)
FIG. 29 Gene expression testing market , 2012 – 2022 (USD Million)
FIG. 30 Karyology testing market , 2012 – 2022 (USD Million)
FIG. 31 Gene sequencing testing market, 2012 – 2022 (USD Million)
FIG. 32 Cell bank preparation market , 2012 – 2022 (USD Million)
FIG. 33 Master cell bank preparation market , 2012 – 2022 (USD Million)
FIG. 34 Working cell bank preparation market , 2012 – 2022 (USD Million)
FIG. 35 Cell banking market share, by region, 2014 & 2022
FIG. 36 North America cell banking market, 2012 – 2022 (USD Million)
FIG. 37 U.S. cell banking market, 2012 – 2022 (USD Million)
FIG. 38 Canada cell banking market, 2012 – 2022 (USD Million)
FIG. 39 Europe cell banking market, 2012 – 2022 (USD Million)
FIG. 40 Germany cell banking market, 2012 – 2022 (USD Million)
FIG. 41 France cell banking market, 2012 – 2022 (USD million)
FIG. 42 UK cell banking market, 2012 – 2022 (USD million)
FIG. 43 Asia Pacific cell banking market, 2012 – 2022 (USD million)
FIG. 44 Japan cell banking market, 2012 – 2022 (USD million)
FIG. 45 China cell banking market, 2012 – 2022 (USD million)
FIG. 46 India cell banking market, 2012 – 2022 (USD million)
FIG. 47 Korea cell banking market, 2012 – 2022 (USD million)
FIG. 48 Singapore cell banking market, 2012 – 2022 (USD million)
FIG. 49 Latin America cell banking market, 2012 – 2022 (USD million)
FIG. 50 Brazil cell banking market, 2012 – 2022 (USD million)
FIG. 51 Mexico cell banking market, 2012 – 2022 (USD million)
FIG. 52 MEA cell banking market, 2012 – 2022 (USD million)
FIG. 53 South Africa cell banking market, 2012 – 2022 (USD million)



★調査レポート[セルバンキングアウトソーシングの世界市場] (コード:GVR808SP22PL)販売に関する免責事項を必ずご確認ください。
★調査レポート[セルバンキングアウトソーシングの世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆